Institutional investors purchased a net $964.1 thousand shares of RGLS during the quarter ended September 2015. This may signal that the smart money is gaining interest in this company as the 64.44% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
COLUMBIA PARTNERS LLC INVESTMENT... Bought 424.2 Thousand shares of Regulus Therapeutics Inc